SMTL ID : 8du3.1

Crystal structure of A2AAR-StaR2-bRIL in complex with compound 21a

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x TKO: (4M)-6-bromo-4-(furan-2-yl)quinazolin-2-amine(Non-covalent)

TKO.1: 14 residues within 4Å: Chain A: A.88, I.91, V.109, L.110, F.193, E.194, M.199, M.202, W.367, L.370, H.371, N.374, M.391, I.395 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.91, A:L.110, A:F.193, A:W.367, A:I.395 Hydrogen bonds: A:N.374, A:N.374 Salt bridges: A:E.194 pi-Stacking: A:F.193, A:F.193

3 x CLR: CHOLESTEROL(Non-covalent)

CLR.2: 8 residues within 4Å: Chain A: L.368, P.369, I.372, C.383, S.384, L.390 Ligands: OLA.21, OLA.22 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.368, A:P.369, A:I.372, A:L.390 Hydrogen bonds: A:S.384, A:S.384 CLR.3: 8 residues within 4Å: Chain A: L.212, C.375, F.376, F.379, C.380 Ligands: OLC.7, OLA.22, OLA.25 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.212, A:F.376, A:F.376, A:F.376, A:F.379, A:F.379 CLR.4: 9 residues within 4Å: Chain A: F.87, F.95, A.97, A.98, G.101, I.105, Q.188 Ligands: OLC.5, OLA.24 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.87, A:F.95, A:A.97, A:I.105 Hydrogen bonds: A:A.98, A:Q.188

4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.5: 10 residues within 4Å: Chain A: V.82, L.83, P.86, F.87, T.90, F.95, C.96, Q.188 Ligands: CLR.4, OLA.10 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.82, A:L.83, A:P.86, A:F.87, A:T.90, A:F.95 Hydrogen bonds: A:C.96, A:Q.188 OLC.6: 9 residues within 4Å: Chain A: C.53, V.56, W.57, Y.68, V.71, A.75 Ligands: OLC.8, OLA.18, OLA.24 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.57, A:V.71 OLC.7: 7 residues within 4Å: Chain A: F.208, L.212, F.379, P.381, D.382 Ligands: CLR.3, OLA.19 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.208, A:L.212, A:F.379, A:F.379, A:F.379 Water bridges: A:D.382 OLC.8: 9 residues within 4Å: Chain A: Y.68, S.72, G.143, I.150, W.154, F.158 Ligands: OLC.6, OLA.13, OLA.24 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.150, A:W.154, A:W.154, A:W.154, A:F.158 Hydrogen bonds: A:G.143

17 x OLA: OLEIC ACID(Non-covalent)

OLA.9: 8 residues within 4Å: Chain A: G.30, V.37, W.389, Y.392, L.393, V.396 Ligands: OLA.15, OLA.16 Ligand excluded by PLIP OLA.10: 6 residues within 4Å: Chain A: V.82, T.90, T.93, F.95 Ligands: OLC.5, OLA.11 Ligand excluded by PLIP OLA.11: 4 residues within 4Å: Chain A: I.28, I.35, T.93 Ligands: OLA.10 Ligand excluded by PLIP OLA.12: 6 residues within 4Å: Chain A: F.69, A.122, I.125, D.126, V.141, I.149 Ligand excluded by PLIP OLA.13: 8 residues within 4Å: Chain A: A.147, I.150, A.151, W.154, V.155, F.158, A.159 Ligands: OLC.8 Ligand excluded by PLIP OLA.14: 2 residues within 4Å: Chain A: I.152, L.156 Ligand excluded by PLIP OLA.15: 4 residues within 4Å: Chain A: T.400, V.404, F.407 Ligands: OLA.9 Ligand excluded by PLIP OLA.16: 2 residues within 4Å: Chain A: W.389 Ligands: OLA.9 Ligand excluded by PLIP OLA.17: 2 residues within 4Å: Chain A: W.57 Ligands: OLA.18 Ligand excluded by PLIP OLA.18: 6 residues within 4Å: Chain A: C.53, W.54, W.57, I.78 Ligands: OLC.6, OLA.17 Ligand excluded by PLIP OLA.19: 6 residues within 4Å: Chain A: Y.204, F.208, V.213, L.216, F.378 Ligands: OLC.7 Ligand excluded by PLIP OLA.20: 2 residues within 4Å: Chain A: M.165, L.166 Ligand excluded by PLIP OLA.21: 4 residues within 4Å: Chain A: P.387, W.389, L.393 Ligands: CLR.2 Ligand excluded by PLIP OLA.22: 5 residues within 4Å: Chain A: I.372, F.376, C.383 Ligands: CLR.2, CLR.3 Ligand excluded by PLIP OLA.23: 4 residues within 4Å: Chain A: I.28, S.32, T.36, L.39 Ligand excluded by PLIP OLA.24: 6 residues within 4Å: Chain A: L.83, F.104, F.108 Ligands: CLR.4, OLC.6, OLC.8 Ligand excluded by PLIP OLA.25: 8 residues within 4Å: Chain A: L.212, L.215, L.219, Y.222, F.226, A.357, A.360 Ligands: CLR.3 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bolteau, R. et al., High ligand efficiency quinazoline compounds as novel A 2A adenosine receptor antagonists. Eur.J.Med.Chem. (2022)

Release Date

2022-08-10

Peptides

Adenosine receptor A2a, soluble cytochrome b562 chimera,Soluble cytochrome b562,Adenosine receptor A2a: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Adenosine receptor A2a, soluble cytochrome b562 chimera,Soluble cytochrome b562,Adenosine receptor A2a

Related Entries With Identical Sequence